Literature DB >> 32302613

Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes.

Rasmus Iversen1, Sunniva F Amundsen1, Liv Kleppa1, M Fleur du Pré1, Jorunn Stamnaes1, Ludvig M Sollid2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32302613     DOI： 10.1053/j.gastro.2020.04.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

1.  Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions.

Authors:  María Roca; Ester Donat; Etna Masip; Verónica Ballester; Isabel Gómez; Mercedes SanFelix; David Ramos; Joaquim Calvo-Lerma; Lola Giner-Pérez; Miguel Bolonio; Begoña Polo; Carmen Ribes-Koninckx
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

Review 2.  Single-cell approaches to dissect adaptive immune responses involved in autoimmunity: the case of celiac disease.

Authors:  Ida Lindeman; Ludvig M Sollid
Journal:  Mucosal Immunol       Date:  2021-09-16       Impact factor: 7.313

3.  Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions.

Authors:  María Roca; Ester Donat; Etna Masip; Verónica Ballester; Isabel Gómez; Mercedes SanFelix; David Ramos; Joaquim Calvo-Lerma; Lola Giner-Pérez; Miguel Bolonio; Begoña Polo; Carmen Ribes-Koninckx
Journal:  Clin Exp Immunol       Date:  2021-11-18       Impact factor: 5.732

4.  Wheat Amylase Trypsin Inhibitors Aggravate Intestinal Inflammation Associated with Celiac Disease Mediated by Gliadin in BALB/c Mice.

Authors:  Tian Yu; Shuai Hu; Fangfang Min; Jingjing Li; Yunpeng Shen; Juanli Yuan; Jinyan Gao; Yong Wu; Hongbing Chen
Journal:  Foods       Date:  2022-05-25

Review 5.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

6.  Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling.

Authors:  Yuanyuan Hou; Xi Xiao; Wei Yu; Sihua Qi
Journal:  J Immunol Res       Date:  2021-08-24       Impact factor: 4.818

7.  TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.

Authors:  Christian B Lindstad; Alisa E Dewan; Jorunn Stamnaes; Ludvig M Sollid; M Fleur du Pré
Journal:  PLoS One       Date:  2021-11-03       Impact factor: 3.240

8.  Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease.

Authors:  Ádám Diós; Bharani Srinivasan; Judit Gyimesi; Katharina Werkstetter; Rudolf Valenta; Sibylle Koletzko; Ilma R Korponay-Szabó
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

Review 9.  Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.

Authors:  Jordan Voisine; Valérie Abadie
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

Review 10.  Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.

Authors:  Helka Kaunisto; Teea Salmi; Katri Lindfors; Esko Kemppainen
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.